Skip to content

Assessing the Clinical Efficacy of Transforaminal Endoscopic Lumbar Discectomy in the treatment of Discogenic Low Back Pain with HIZ

Assessing the Clinical Efficacy of Transforaminal Endoscopic Lumbar Discectomy in the treatment of Discogenic Low Back Pain with HIZ

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066508
Enrollment
Unknown
Registered
2022-12-07
Start date
2021-10-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Discogenic low back pain

Interventions

group A:Transforaminal Endoscopic Lumbar Discectomy
group B:coblation nucleoplasty

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? 18 = age = 70 years old, regardless of gender ? The course of chronic lumbago or non-radicular lower extremity pain was more than 6 months, the head did not exceed the thoracolumbar junction, the distal end did not exceed the knee, and conservative treatment was ineffective ? Imaging examination showed a high signal area at the posterior edge of the annulus fibrosus of the single-segment intervertebral disc. ? VAS score > 3, full score 10. ? Participate in the study voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: ? With obvious neurological symptoms of lower limbs ? Imaging examination showed spinal stenosis and lumbar instability ? Lumbago caused by trauma, tumor and infection ? Endocrine system diseases: pituitary tumor, severe diabetes, hypercortisolism, pheochromocytoma, etc ? Mental and psychological diseases: such as schizophrenia, depression, history of taking chronic analgesic drugs, history of alcoholism, opioid dependence or inability to understand visual analog scale (visual analogue scale) ? Pregnant women or puerpera ? The situation that other researchers think is not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
MacNab efficacy evaluation criteria;quality of recovery-15;The Oswestry Disability Index;

Countries

China

Contacts

Public ContactWang Likui

First Affiliated Hospital of Anhui Medical University

wlk9560@163.com+86 137 0569 0702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026